Sign up to save your podcasts
Or
Share Vera Mucaj on The Power of Real-World Data to Augment Clinical Trials and Transform Healthcare
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Vera Mucaj on The Power of Real-World Data to Augment Clinical Trials and Transform Healthcare
In this episode, we chat with Vera M., a cancer researcher-turned-chief scientific officer-turned-biotech founder. We dive into what makes healthcare data “good,” the challenges of connecting siloed clinical trial data to the real world, and the evolving infrastructure powering data-driven medicine. Vera shares her journey from the lab to consulting to startups, and we explore the current and future state of real-world data, patient matching, and tokenization.
TIMESTAMPS:
(00:00) Meet our first guest: Vera Mucaj
(01:00) From cancer research to Datavent
(03:00) Why consulting became the next step
(05:00) Startup life
(06:00) Linking trials to real-world data
(09:00) The problem with siloed trial data
(11:00) What happens after a trial ends?
(15:00) Are we underusing trial data?
(17:00) The evolution of informed consent
(20:00) Ethics vs access
(26:00) Real-world data is still early
(29:00) Observational limits & FDA guidance
(32:00) Can RWD replicate trial results?
(34:00) Data context is everything
(36:00) Could consumer data help healthcare?
(39:00) Why data decisions take so long
(44:00) Product tip: No one wants your dashboard
(47:00) Vera’s Nature paper on patient matching
(51:00) The penny-drop moment for linkage
(52:00) What Vera’s building next
(55:00) Advice for pivoting PhDs
(57:00) Wrap-up and reflections
🔗Links & Resources:
Vera’s Nature article on patient matching
Flex Capital
Datavent
FDA’s guidance on real-world evidence
🔔 Subscribe For deep dives and guest interviews about healthcare data, AI, and the future of health tech.
🎙️ About High Dimensional Health Data (HD²) HD² is the podcast for people building healthcare's data and AI future. Hosted by Aaron and Phil, HD² explores the intersection of healthcare, data, and AI, and focuses on conversations with builders and practitioners.
Hosts
Phil Ballentine – Sr Director, Data Engineering at Atropos Health
🔗 https://www.linkedin.com/in/phil-ballentine/
Aaron Neiderhiser – Co-Founder and CEO at Tuva Health
🔗 https://www.linkedin.com/in/aaronneiderhiser/
Guests
Vera Mucaj – Venture Partner at Flex Capital & Former Chief Scientific Officer at Datavent
🔗https://www.linkedin.com/in/veramucaj/
Interested in working together or coming on the podcast as a guest? Email us at [email protected]
View all episodes
By highdimensionalIn this episode, we chat with Vera M., a cancer researcher-turned-chief scientific officer-turned-biotech founder. We dive into what makes healthcare data “good,” the challenges of connecting siloed clinical trial data to the real world, and the evolving infrastructure powering data-driven medicine. Vera shares her journey from the lab to consulting to startups, and we explore the current and future state of real-world data, patient matching, and tokenization.
TIMESTAMPS:
(00:00) Meet our first guest: Vera Mucaj
(01:00) From cancer research to Datavent
(03:00) Why consulting became the next step
(05:00) Startup life
(06:00) Linking trials to real-world data
(09:00) The problem with siloed trial data
(11:00) What happens after a trial ends?
(15:00) Are we underusing trial data?
(17:00) The evolution of informed consent
(20:00) Ethics vs access
(26:00) Real-world data is still early
(29:00) Observational limits & FDA guidance
(32:00) Can RWD replicate trial results?
(34:00) Data context is everything
(36:00) Could consumer data help healthcare?
(39:00) Why data decisions take so long
(44:00) Product tip: No one wants your dashboard
(47:00) Vera’s Nature paper on patient matching
(51:00) The penny-drop moment for linkage
(52:00) What Vera’s building next
(55:00) Advice for pivoting PhDs
(57:00) Wrap-up and reflections
🔗Links & Resources:
Vera’s Nature article on patient matching
Flex Capital
Datavent
FDA’s guidance on real-world evidence
🔔 Subscribe For deep dives and guest interviews about healthcare data, AI, and the future of health tech.
🎙️ About High Dimensional Health Data (HD²) HD² is the podcast for people building healthcare's data and AI future. Hosted by Aaron and Phil, HD² explores the intersection of healthcare, data, and AI, and focuses on conversations with builders and practitioners.
Hosts
Phil Ballentine – Sr Director, Data Engineering at Atropos Health
🔗 https://www.linkedin.com/in/phil-ballentine/
Aaron Neiderhiser – Co-Founder and CEO at Tuva Health
🔗 https://www.linkedin.com/in/aaronneiderhiser/
Guests
Vera Mucaj – Venture Partner at Flex Capital & Former Chief Scientific Officer at Datavent
🔗https://www.linkedin.com/in/veramucaj/
Interested in working together or coming on the podcast as a guest? Email us at [email protected]